Singapore markets closed

Zimmer Biomet Holdings, Inc. (ZBH)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
120.18-1.05 (-0.87%)
At close: 04:03PM EDT
120.40 +0.22 (+0.18%)
After hours: 05:59PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close121.23
Open121.30
Bid119.00 x 900
Ask126.80 x 1100
Day's range119.56 - 121.30
52-week range102.00 - 147.50
Volume1,136,973
Avg. volume1,273,033
Market cap24.724B
Beta (5Y monthly)1.03
PE ratio (TTM)26.07
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yield0.96 (0.79%)
Ex-dividend date26 Jun 2024
1y target estN/A
  • PR Newswire

    Zimmer Biomet Announces Quarterly Dividend for Second Quarter of 2024

    Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the second quarter of 2024. The cash dividend of $0.24 per share is payable on or about July 31, 2024 to stockholders of record as of the close of business on June 26, 2024.

  • PR Newswire

    Zimmer Biomet Publishes 2023 Sustainability Report

    Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today published its 2023 Sustainability Report which provides an overview of the company's environmental, social and governance (ESG) program, progress, and accomplishments. The report outlines Zimmer Biomet's formal commitment with Science Based Targets initiative (SBTi) to reach Net-Zero greenhouse gas (GHG) emissions by 2050 and aligns with the Sustainability Accounting Standards Board (SASB) framework and t

  • PR Newswire

    Zimmer Biomet Announces First Quarter 2024 Financial Results

    Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today reported financial results for the quarter ended March 31, 2024. The Company reported first quarter net sales of $1.889 billion, an increase of 3.2% over the prior year period, and an increase of 4.4% on a constant currency1 basis. Net earnings for the first quarter were $172.4 million, or $399.7 million on an adjusted1 basis.